Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 42.55%
March 31, 2026 39.74%
December 31, 2025 38.19%
September 30, 2025 39.12%
June 30, 2025 41.02%
March 31, 2025 38.99%
December 31, 2024 38.67%
September 30, 2024 38.54%
June 30, 2024 40.82%
March 31, 2024 38.70%
December 31, 2023 39.11%
September 30, 2023 38.71%
June 30, 2023 37.54%
March 31, 2023 35.52%
December 31, 2022 31.93%
September 30, 2022 32.01%
June 30, 2022 32.67%
March 31, 2022 34.54%
December 31, 2021 35.06%
September 30, 2021 35.48%
June 30, 2021 36.02%
March 31, 2021 35.81%
December 31, 2020 36.82%
September 30, 2020 34.53%
June 30, 2020 36.45%
Date Value
March 31, 2020 37.82%
December 31, 2019 36.29%
September 30, 2019 35.50%
June 30, 2019 36.73%
March 31, 2019 37.62%
December 31, 2018 36.50%
September 30, 2018 35.85%
June 30, 2018 37.01%
March 31, 2018 38.24%
December 31, 2017 35.22%
September 30, 2017 36.19%
June 30, 2017 37.28%
March 31, 2017 38.08%
December 31, 2016 37.20%
September 30, 2016 37.17%
June 30, 2016 35.84%
March 31, 2016 36.32%
December 31, 2015 36.84%
September 30, 2015 35.03%
June 30, 2015 36.92%
March 31, 2015 36.94%
December 31, 2014 36.39%
September 30, 2014 35.87%
June 30, 2014 35.10%
March 31, 2014 35.91%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Cencora, Inc. 3.93%
Abbott Laboratories 52.64%
Align Technology, Inc. 71.71%
AngioDynamics, Inc. 50.87%
Accuray, Inc. 34.76%